The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it buy, with a mean price target of $154.
Palomar Holdings, Inc.
PLMR · Nasdaq · USD · Market cap $3.6B · 439 employees
Palomar Holdings, Inc., a specialty insurance company, provides property and casualty insurance to individuals and businesses in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-04
Screened 2026-09-04 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Palomar Holdings, Inc. holds its Accumulation at $136.58. Elevated stress, defensive posture warranted, held for 184 days.
| Phase | Accumulation |
| Quantitative state | Elevated stress, defensive posture warranted, held for 184 days |
| Price at the screen | $136.58 |
| Valuation | 18.36 trailing · 12.02 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.39 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: insurance
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: insurance | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-04 screen. The gold marker is the market price at the same screen. A 23.0% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits +22% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsInsurance growth story that still fails our test
Insurance pays out when homes shake or businesses burn, yet the sector itself lands on our prohibited list every time. Palomar shows 60% revenue growth, 20% profit margins and 23% ROE, with shares trading at 12.1 times forward earnings against a $166 consensus target. None of that matters once the ethical screen triggers.
We pass because the rule is clear and non-negotiable. The same filter kept us away from other names that otherwise looked attractive on paper. Strong metrics cannot override a hard sector exclusion.
Valuation sits below our calculated fair value, yet opportunity rating stays at none. Currency and catastrophe exposure add further uncertainty for any property-casualty book. Analysis, not advice.
| Forward P/E | 12.0xcheap for a company growing this fast |
| Trailing P/E | 18.4xreasonably valued |
| EPS, trailing | 7.44 |
| EPS, forward | 11.37 |
| Revenue growth | +54.7%growing very fast |
| Profit margin | 18.6%healthy profit margins |
| Return on equity | 22.2%an exceptional return on shareholder capital |
| FCF yield | 15.74% |
| Debt to equity | 0.30minimal debt: a conservative balance sheet |
| Current ratio | 0.54below 1: short-term bills exceed liquid assets |
| Beta | 0.39barely tracks the market's swings |
| Short interest, float | 0.04% |
| 52-week range | 100.81 - 147.62 |
| Market cap | $3.6B |
| Employees | 439 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePLMR trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it buy, with a mean price target of $154.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it buy, with a mean price target of $154.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $109.22 | +4.0% | · | $1,040 | +4.0% |
| 2 months | $127.80 | -11.1% | · | $889 | -11.1% |
| 3 months | $119.80 | -5.2% | · | $948 | -5.2% |
| 6 months | $122.29 | -7.1% | · | $929 | -7.1% |
| 1 year | $156.87 | -27.6% | · | $724 | -27.6% |
| 2 years | $86.00 | +32.1% | · | $1,321 | +32.1% |
| 3 years | $59.06 | +92.4% | · | $1,924 | +92.4% |
| 5 years | $76.32 | +48.9% | · | $1,489 | +48.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PLMR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.